Skip to content
About us
Our DNA
Board members
Our leadership
Partners
Pipeline
VTX-801 – Wilson’s disease
> VTX-801 in Wilson disease – GATEWAY – Phase 1/2 Clinical Trial
VTX-802 & VTX-803 – PFIC
VTX-804 – Citrullinemia Type 1
VTX–806 – Cerebrotendinous Xanthomatosis
Investors
News
Events
Patients & Families
Patient’s Stories
Patient advocacy
Patient & Families ressources
Compassionate Use and Expanded Access
Work at Vivet
Menu
About us
Our DNA
Board members
Our leadership
Partners
Pipeline
VTX-801 – Wilson’s disease
> VTX-801 in Wilson disease – GATEWAY – Phase 1/2 Clinical Trial
VTX-802 & VTX-803 – PFIC
VTX-804 – Citrullinemia Type 1
VTX–806 – Cerebrotendinous Xanthomatosis
Investors
News
Events
Patients & Families
Patient’s Stories
Patient advocacy
Patient & Families ressources
Compassionate Use and Expanded Access
Work at Vivet
Our leadership
Our DNA
>
Board members
>
Our leadership
>
Partners
>
Co-founder & CEO
Jean-Philippe Combal, PharmD, PhD
Co-Founder & CSO
Dr Gloria Gonzalez-Aseguinolaza, PhD
Chief Medical Officer
Bernard Bénichou, M.D., Ph.D
Chief Operating Officer
Dr Anne Douar, PhD
General Counsel & Head of Finance
Susan Coles
